key: cord-0832964-jdyouzqg
authors: Roncati, Luca; Lusenti, Beatrice
title: The «moonlighting protein» able to explain the T(h)1 immune lockdown in severe COVID-19()
date: 2020-07-09
journal: Med Hypotheses
DOI: 10.1016/j.mehy.2020.110087
sha: aafdc3f268d731c882b42de0d84e8bdf4a844ee5
doc_id: 832964
cord_uid: jdyouzqg

COVID-19 is a major public health issue around the world and new data about its etiological agent, SARS-CoV-2, are urgently necessary, also translating the scientific knowledge acquired on its more similar predecessors, SARS-CoV-1 and MERS-CoV, the coronaviruses responsible for SARS and MERS, respectively. Like SARS-CoV-1, SARS-CoV-2 exploits the ACE2 receptors to enter the host cells; nevertheless, recent bioinformatics insights suggest a potential interaction of SARS-CoV-2 with the «moonlighting protein» CD26/DPP4, exactly how MERS-CoV works. CD26/DPP4 is overexpressed on T-helper type 1 (T(h)1) cells and its expression increases with aging, all factors which could well explain the T(h)1 immune lockdown, especially in the elderly, during fatal SARS-CoV-2 infections. Facing with this scenario, it is possible that T(h)1 and T-cytotoxic lymphocytes are the immune cells most affected by SARS-CoV-2, and that the immune system is forced to mount a T-helper type 2 (T(h)2) response, the only one still mountable, in the attempt to counteract the viral load. However, in this way, the symptomatic patient experiences all the negative effects of the T(h)2 response, which can seriously aggravate the clinical picture.

COVID-19 is a major public health issue around the world and new data about its etiological agent, SARS-CoV-2, are urgently necessary, also translating the scientific knowledge acquired on its more similar predecessors, SARS-CoV-1 and MERS-CoV, the coronaviruses responsible for SARS and MERS, respectively. Like SARS-CoV-1, SARS-CoV-2 exploits the ACE2 receptors to enter the host cells; nevertheless, recent bioinformatics insights suggest a potential interaction of SARS-CoV-2 with the «moonlighting protein» CD26/DPP4, exactly how MERS-CoV works. CD26/DPP4 is overexpressed on T-helper type 1 (Th1) cells and its expression increases with aging, all factors which could well explain the Th1 immune lockdown, especially in the elderly, during fatal SARS-CoV-2 infections. Facing with this scenario, it is possible that Th1 and T-cytotoxic lymphocytes are the immune cells most affected by SARS-CoV-2, and that the immune system is forced to mount a Thelper type 2 (Th2) response, the only one still mountable, in the attempt to counteract the viral load. However, in this way, the symptomatic patient experiences all the negative effects of the Th2 response, which can seriously aggravate the clinical picture.

coronavirus disease 19 (COVID-19); severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2); Middle-East-respiratory-syndrome-related-coronavirus (MERS-CoV); dipeptidyl peptidase-4 (DPP-4); cluster of differentiation 26 (CD26); T-helper type 1 (Th1); T-helper type 2 (Th2). 2 Coronavirus disease 2019 (COVID-19) is a major public health issue around the world and new data about its etiological agent, the severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2), are urgently necessary, also translating the scientific knowledge acquired on its more similar predecessors, the severe-acute-respiratory-syndrome-coronavirus-1 (SARS-CoV-1) and the Middle-East-respiratory-syndrome-related-coronavirus (MERS-CoV), the coronaviruses responsible for SARS and MERS, respectively. The discovery of MERS-CoV dates back to 2012, when it was initially identified in Saudi Arabia [1] . Also known as «camel flu», MERS is a potentially severe respiratory illness with a lethality rate of around 34% and today is still circulating among the population, in particular of the Arabian Peninsula, without a fully protective vaccine available [2] .

Subsequent studies on MERS-CoV have highlighted that the virus enters the host cell through cluster of differentiation 26 (CD26), alias dipeptidyl peptidase-4 (DPP-4) receptor [3] . This «moonlighting protein»* is highly conserved across species, datum which explains the possible infection in camels and bats, and it is mainly expressed in the human bronchial epithelium and kidneys, as well as memory and naїve T lymphocytes [4] . In particular, it has been found overexpressed in T-helper type 1 (Th1) rather than T-helper type 2 (Th2) cells, and its expression in Th1 increases with aging [5] [6] [7] .

As well known, naїve T-helper cells (Th0) can detect novel pathogens never encountered before, as is the current case of SARS-CoV-2. Depending on the infectious agent, Th0 then polarize the immune response into Th1, the default response in immunocompetent subjects to intracellular or phagocytosable pathogens (e.g. viruses, bacteria, protozoa, fungi) and mediated by macrophages and T-cytotoxic (Tc) cells, or into Th2, classically directed against extracellular non-phagocytosable pathogens (e.g. helminths), whose main effectors are eosinophils, basophils, mastocytes and B cells [8] . During our researches on COVID-19, for many clinic-laboratory aspects including lymphopenia quite similar to MERS, we have disclosed that the immune system mounts a Th2 response against SARS-CoV-2 in patients requiring intensive care, rather than a Th1 response, which would keep the infection under control by means of macrophages and Tc cells [9] . In addition, for the first time in worldwide literature, we have provide evidence that a life-threatening escalation from Th2 immune 3 response to type 3 hypersensitivity (immune complex disease) in COVID-19 vasculitis takes place, and that the inflamed smooth muscle cells of blood vessels concur to the «cytokine storm» via interleukin-6 [10] [11] . In the last four months, two independent bioinformatics research groups have reported that the spike glycoprotein of SARS-CoV-2 not only binds the angiotensin converting enzyme 2 (ACE2) receptors [12] , the same entry mechanism exploited by SARS-CoV-1, but potentially interacts also with CD26/DPP-4, a proposed pivotal event for hijacking and virulence, exactly how MERS-CoV works [13, 14] . Faced with this scenario, it is possible that Th1 and Tc lymphocytes are the immune cells most affected by the viral load, especially in the elderly, and that the immune system is forced to mount a Th2 response, the only one still mountable, in the attempt to counteract the pathogen by the action of Th2 effectors (Fig. 1) . However, in this way, the symptomatic patient experiences all the negative effects of the Th2 response, which can seriously aggravate the clinical picture.

Conflict of interest statement: no conflict of interest. 

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Middle East respiratory syndrome coronavirus (MERS-CoV)

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Expression of CD26 (dipeptidyl peptidase IV) on memory and naive T lymphocytes

Molecules associated with human Th1 or Th2 cells

Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets

Altered Th1/Th2 commitment in human CD4+ T cells with ageing

Type 1/Type 2 immunity in infectious diseases

Signals of Th2 immune response from COVID-19 patients requiring intensive care

Type 3 hypersensitivity in COVID-19 vasculitis

What about the original antigenic sin of the humans versus SARS-CoV-2?

Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2

Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26

The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike